Review

Neuroendocrine Neoplasms of the Urinary Bladder: Integrating Molecular Advances into a Refined Classification System

A. Lobo Liang Cheng

Aug 2026 · Endocrine pathology · Vol 37 · 0 citations · 176 references

Medicine

TL;DR

A refined, bladder-specific framework that incorporates proliferative indices, molecular alterations, and recognition of mixed neuroendocrine–non-neuroendocrine neoplasms is proposed, with the goal of improving diagnostic reproducibility and informing future biomarker-driven therapeutic strategies.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Sep 2026

Immunohistochemical stratification of bladder small cell carcinoma reveals two major phenotypes with distinct therapeutic biomarker profiles.

Low membranous Nectin-4 expression and preferential DLL3 and SLFN11 expression in High-NE tumours support further investigation of alternative therapeutic strategies, and SmCCB may be stratified into two IHC-defined phenotypic groups with distinctive neuroendocrine differentiation and therapeutic biomarker profiles.

N. Tenace, M. Colecchia, A. Hartmann et al. · Histopathology · 0 citations

Review Open access Sep 2026

BREAST CANCER WITH NEUROENDOCRINE DIFFERENTIATION - THE CURRENT STATE OF KNOWLEDGE AND CLINICAL IMPLICATIONS

The current state of knowledge on BNETs is summarized and clinical implications for practicing oncologists are discussed, with emphasis on pathomorphological features, diagnosis, treatment, and prognosis.

Jonasz Żuk, K. Bukała, Szymon Klimaszewski et al. · International Journal of Inn... · 0 citations

Review Open access Sep 2026

Immunological Features of Neuroendocrine Neoplasms and Adrenal Tumors

The immunological features of representative neuroendocrine and adrenal tumors (neuroendocrine tumor, neuroendocrine carcinoma, adrenocortical carcinoma, and pheochromocytoma/paraganglioma) are examined, suggesting a potential benefit observed in selected subgroups.

A. Ohmoto, Shunji Takahashi, Shigehisa Kitano · Cancer Medicine · 0 citations

Open access Aug 2026

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids

Lung neuroendocrine tumours (NETs, also known as carcinoids) are rapidly rising in incidence worldwide but have unknown aetiology and limited therapeutic options beyond surgery. The current WHO classification, based on mitotic count and presence or absence of necrosis, divides lung NETs into grade-1 typical, and grade-...

A. Sexton-Oates, É. Mathian, N. Candeli et al. · Molecular Cancer · 1 citation

Open access Sep 2026

AI-powered histopathology classifiers identify transcriptomic biomarkers associated with cell cycle regulation and increased mitotic activity in poorly differentiated neuroendocrine carcinoma

An integrative multi-omics framework for molecular classification of NENs that complements traditional histopathological assessment is established and enables improved tumor stratification, identification of mixed or misclassified cases and supports the development of biomarker-driven diagnostic and therapeutic strateg...

Timothy Khumpan, Kasonde Chewe, Namrata Vijayvergia et al. · Human Genomics · 0 citations

Review Open access Sep 2026

Historical Evolution of Terminology and Current Classification of Neuroendocrine Neoplasms of the Larynx and Mixed Neuroendocrine–Non-Neuroendocrine Neoplasms (MiNENs): A Narrative Review

This is a narrative review that describes the evolution of terminology and classification schemes of neuroendocrine tumors (NETs), neuroendocrine carcinomas (NECs), mixed neuroendocrine–non-neuroendocrine neoplasms (MiNENs), and paragangliomas of the larynx, with the contribution of immunohistochemistry and treatment o...

Martina Bradová, Abbas Agaimy, A. Ferlito · Diagnostics · 0 citations